Trials / Active Not Recruiting
Active Not RecruitingNCT02808780
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 537 (actual)
- Sponsor
- Janssen Biotech, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the long-term safety risks in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi.
Conditions
Timeline
- Start date
- 2016-12-16
- Primary completion
- 2026-12-10
- Completion
- 2027-03-11
- First posted
- 2016-06-22
- Last updated
- 2026-03-13
Locations
63 sites across 9 countries: United States, Austria, Canada, Czechia, France, Germany, Greece, South Korea, Spain
Source: ClinicalTrials.gov record NCT02808780. Inclusion in this directory is not an endorsement.